223 related articles for article (PubMed ID: 8786380)
1. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis.
Ikonomidou C; Qin Qin Y; Labruyere J; Olney JW
J Neuropathol Exp Neurol; 1996 Feb; 55(2):211-24. PubMed ID: 8786380
[TBL] [Abstract][Full Text] [Related]
2. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Dysfunction during the Early Stages of Excitotoxic Spinal Motor Neuron Degeneration in Vivo.
Santa-Cruz LD; Guerrero-Castillo S; Uribe-Carvajal S; Tapia R
ACS Chem Neurosci; 2016 Jul; 7(7):886-96. PubMed ID: 27090876
[TBL] [Abstract][Full Text] [Related]
4. Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - vulnerability of lower motor neurons to proximal excitotoxicity.
Blizzard CA; Southam KA; Dawkins E; Lewis KE; King AE; Clark JA; Dickson TC
Dis Model Mech; 2015 Mar; 8(3):215-24. PubMed ID: 25740331
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
6. Imbalanced excitatory to inhibitory synaptic input precedes motor neuron degeneration in an animal model of amyotrophic lateral sclerosis.
Schütz B
Neurobiol Dis; 2005 Oct; 20(1):131-40. PubMed ID: 16137574
[TBL] [Abstract][Full Text] [Related]
7. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
8. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.
Zhang B; Tu P; Abtahian F; Trojanowski JQ; Lee VM
J Cell Biol; 1997 Dec; 139(5):1307-15. PubMed ID: 9382875
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance microimaging of the spinal cord in the SOD1 mouse model of amyotrophic lateral sclerosis detects motor nerve root degeneration.
Cowin GJ; Butler TJ; Kurniawan ND; Watson C; Wallace RH
Neuroimage; 2011 Sep; 58(1):69-74. PubMed ID: 21689764
[TBL] [Abstract][Full Text] [Related]
10. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
Pehar M; Cassina P; Vargas MR; Castellanos R; Viera L; Beckman JS; Estévez AG; Barbeito L
J Neurochem; 2004 Apr; 89(2):464-73. PubMed ID: 15056289
[TBL] [Abstract][Full Text] [Related]
11. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).
Dal Canto MC; Gurney ME
Brain Res; 1995 Apr; 676(1):25-40. PubMed ID: 7796176
[TBL] [Abstract][Full Text] [Related]
12. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
[TBL] [Abstract][Full Text] [Related]
13. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
Li J; Li T; Zhang X; Tang Y; Yang J; Le W
Neurobiol Aging; 2014 Apr; 35(4):837-46. PubMed ID: 24126158
[TBL] [Abstract][Full Text] [Related]
14. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
15. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
[TBL] [Abstract][Full Text] [Related]
16. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.
Mourelatos Z; Gonatas NK; Stieber A; Gurney ME; Dal Canto MC
Proc Natl Acad Sci U S A; 1996 May; 93(11):5472-7. PubMed ID: 8643599
[TBL] [Abstract][Full Text] [Related]
17. Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis.
Jokic N; Ling YY; Ward RE; Michael-Titus AT; Priestley JV; Malaspina A
J Neurochem; 2007 Dec; 103(5):1821-33. PubMed ID: 17956549
[TBL] [Abstract][Full Text] [Related]
18. Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.
Malaspina A; Ngoh SF; Ward RE; Hall JC; Tai FW; Yip PK; Jones C; Jokic N; Averill SA; Michael-Titus AT; Priestley JV
Neuroscience; 2010 Aug; 169(2):812-27. PubMed ID: 20470869
[TBL] [Abstract][Full Text] [Related]
19. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis.
Graber DJ; Hickey WF; Harris BT
J Neuroinflammation; 2010 Jan; 7():8. PubMed ID: 20109233
[TBL] [Abstract][Full Text] [Related]
20. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
